Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kanamic Network CoFRA:0WT -1.48%92 3-Year EBITDA Growth Rate is 22.60% as of Mar. 2026, which is 1% below its 10-year median of 22.90. GuruFocus rates FRA:0WT with a GF Score™ of 92/100 and a GF Value™ of €3.48. The stock has 3 warning signs investors should review. Among 524 Healthcare Providers & Services companies, Kanamic Network Co ranks better than 69.85% on this metric.
During the past 12 months, Kanamic Network Co's average EBITDA Per Share Growth Rate was 26.40% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 22.60% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 21.30% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 24.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of Kanamic Network Co was 35.50% per year. The lowest was 18.40% per year. And the median was 22.90% per year.
Kanamic Network Co (FRA:0WT) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Kanamic Network Co 3-Year EBITDA Growth Rate Related Terms
FRA:0WT vs VEEV, BTSG, TEM: 3-Year EBITDA Growth Rate Comparison
For the Health Information Services subindustry, Kanamic Network Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kanamic Network Co 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Kanamic Network Co's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Kanamic Network Co's 3-Year EBITDA Growth Rate falls into.
Kanamic Network Co 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 22.60% mean?
Kanamic Network Co (FRA:0WT) has a 3-Year EBITDA Growth Rate of 22.60% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Kanamic Network Co and its competitors. This is near median its historical median of 22.90. Over the past decade, Kanamic Network Co's 3-Year EBITDA Growth Rate has ranged from 18.40 to 35.50. According to the industry distribution chart, Kanamic Network Co ranks #158 out of 524 companies in the Healthcare Providers & Services industry, placing it in the top 30.2%.
Is Kanamic Network Co's 3-Year EBITDA Growth Rate too high?
Kanamic Network Co's current 3-Year EBITDA Growth Rate of 22.60% is near median its 10-year median of 22.90. Over the past 10 years, this metric has ranged from a low of 18.40 to a high of 35.50. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 9.80. Kanamic Network Co's value of 22.60% is 130.6% above this industry median. Based on the distribution chart, Kanamic Network Co ranks #158 out of 524 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Kanamic Network Co has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Kanamic Network Co's 3-Year EBITDA Growth Rate compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Kanamic Network Co ranks #158 out of 524 companies for 3-Year EBITDA Growth Rate. This puts Kanamic Network Co in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 9.80. Kanamic Network Co's value of 22.60% is 130.6% above this benchmark. Historically, Kanamic Network Co's own 3-Year EBITDA Growth Rate has ranged from 18.40 to 35.50 over the past decade. While the company's 10-year median is 22.90 vs. the industry median of 9.80, Kanamic Network Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 9.80, based on 524 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kanamic Network Co's current 3-Year EBITDA Growth Rate of 22.60% is 130.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Kanamic Network Co and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 9.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kanamic Network Co's current 3-Year EBITDA Growth Rate is 22.60%, which is near median its own 10-year median of 22.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kanamic Network Co stock overvalued right now?
Kanamic Network Co (FRA:0WT) has a current 3-Year EBITDA Growth Rate of 22.60%. The stock's GF Value™ is €3.48, compared to a current price of €2.66 — trading 23.6% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 22.60%, which is near median its 10-year median of 22.90 and 130.6% above the Healthcare Providers & Services industry median of 9.80. Kanamic Network Co's overall GF Score™ is 92/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Kanamic Network Co (FRA:0WT), the current 3-Year EBITDA Growth Rate is 22.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kanamic Network Co (FRA:0WT) Overvalued in 2026?
Based on GuruFocus' analysis, Kanamic Network Co stock appears to be undervalued.
The current stock price of €2.66 is trading 23.6% below its estimated GF Value™ of €3.48.
Key valuation signals for FRA:0WT:
3-Year EBITDA Growth Rate: 22.60% (near median its 10-year median of 22.90)
GF Value™: €3.48 vs. price of €2.66 (23.6% below fair value)
Industry Position: 130.6% above the Healthcare Providers & Services median (#158 of 524)
No single metric tells the full story. See the FRA:0WT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kanamic Network Co Ltd provides platforms and management systems for the health care industry. The firm develops software to support medical care and nursing care business management. It offers cloud services for construction of information sharing platform in the medical and nursing care field to local government staff, doctors, nurses, care managers; system integration and system solution business; Website production/management work; and planning, production, and sale of Web content and video, and various sales promotion tools. In addition, it offers management and system consulting services, and education and training services; and engages in planning and holding lectures, seminars, academic conferences.
92GF Score
Get the complete analysis for FRA:0WT
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:0WT has been successfully added to your 
